Navigation Links
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
Date:3/10/2010

netic target classes. The companies will share operational responsibility for the programs until identification of drug candidates, at which stage GSK will assume responsibility for any further preclinical and clinical development and commercialisation.

Under the financial terms, Cellzome will receive an upfront payment of EUR33 million, comprising technology access fees and the purchase of equity. In addition, Cellzome is eligible for milestone payments and tiered royalties for each programme. Milestone payments under this collaboration could reach over EUR475 million if all programmes under the alliance are successfully developed and commercialised.

Tim Edwards, Chief Executive Officer of Cellzome, said: "We are delighted to form another major alliance with GSK, using our leading technology and people to find transformative medicines in this exciting field of biology. Combining forces with GSK will accelerate the development of new anti-inflammatory drugs for the benefit of patients."

About Cellzome

Cellzome is a privately-
'/>"/>

SOURCE Cellzome
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
2. Micromet Announces Proposed Public Offering of Common Stock
3. Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA.
4. MiMedx Group Announces Addition of Sales Director for Europe
5. Arbor Pharmaceuticals Announces the Launch of Pediaderm(TM) HC Complete Kit - A Comprehensive Approach to the Management of Atopic Dermatitis
6. Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
7. INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
8. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
9. BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytrens Contracture
10. Microfluidics Announces Two New Board Members
11. Lexicon Announces Proposed $95 Million Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... New York , July 27, 2015 ... Market Research "Bionics Market - Global Industry Analysis, Size, Share, ... was valued at USD 7.96 billion in 2014, growing at ... for USD 20.49 billion in 2021. The global ... the number of accidents, which is leading to paralysis or ...
(Date:7/27/2015)... CHICAGO , July 27, 2015 The Physician-Patient ... anniversary. PPAHS posted its first blog on July ... a heart beat? ". This post featured ... heart attack outside of a grocery store in ... a 96-minute CPR marathon involving 20 others, who took turns ...
(Date:7/27/2015)... MENLO PARK, Calif. , July ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... accredited investors for a registered direct placement ("Placement") ... 3.35 million common stock purchase warrants for aggregate ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Physician-Patient Alliance for Health & Safety Turns 4 Years Old 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
... Calif., Aug. 29, 2011 Masimo ... of Health Labor & Welfare (MHLW) and Health Canada regulatory ... to quickly and conveniently measure total hemoglobin (SpHb®), SpO2, perfusion ... Hemoglobin is one of the most commonly ...
... Aug. 29, 2011 /PRNewswire-Asia/ -- Winner Medical Group ... or "the Company"), a leading manufacturer of medical ... 100% natural PurCotton® products in China, today announced ... investors to establish Shenzhen PurCotton E-Commerce Co., Ltd.("PurCotton ...
Cached Medicine Technology:Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances 2Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances 3Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances 4Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances 5Winner Medical's PurCotton E-Commerce Sets Sail 2Winner Medical's PurCotton E-Commerce Sets Sail 3Winner Medical's PurCotton E-Commerce Sets Sail 4
(Date:7/28/2015)... , ... July 28, 2015 , ... Want to improve ... – or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises ... an orthopedic spine surgeon at Atlantic Spine Center . , It’s simply ...
(Date:7/27/2015)... , ... July 28, 2015 , ... Almost a year ... to offer behavioral health counseling for persons who are obese and those who are ... less clear. , That mandate will affect any commercial health plan with a program ...
(Date:7/27/2015)... (PRWEB) , ... July 28, 2015 , ... The ... 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is recognized ... over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for ...
(Date:7/27/2015)... , ... July 27, 2015 , ... The heroin epidemic ... reported WCNC on July 7th. The rate for heroin usage has continued ... gone down considerably, and is a less expensive alternative for those with an addiction ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Looking to ... smile? Horizon Blue Cross Blue Shield of New Jersey has enhanced its Dental webpage ... take care of their teeth. , “Horizon is committed to offering our 3.8 ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... reimburses patients and physicians who have been shortchanged ... American Medical Association (AMA), along with the Medical Society ... State Medical Association, claims victory with the settlement agreement ... The $350 million settlement marks the largest monetary settlement ...
... Philadelphia Attorney Stephen Sheller,s Whistleblower Clients Help ... Criminal Fine in Eli Lilly & Company ... 2003 Representing Six Whistleblowers PHILADELPHIA, Jan. 15 ... ("Lilly") will pay federal and state governments ...
... Eli Lilly and Company announced today it has ... pay more than 1.4 billion in criminal and civil ... multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, ... with its market practices for its blockbuster atypical antipsychotic, ...
... transplanted because of the generosity of donors and their familiesPHILADELPHIA, ... kid on the football field, but he spent his life ... graduated high school. For a 16-year-old from Hazleton, Pa. ... certainly unique. But as his father Paul Sr. talked ...
... $515 Million Criminal Fine is Largest Individual Corporate Criminal ... 15 American pharmaceutical giant Eli Lilly and Company ... for promoting its drug Zyprexa for uses not approved ... of Justice announced today. This resolution includes ...
... CINCINNATI, Jan. 15, 2009 The Procter & Gamble,Company ... organizational changes: , -- Mariano ... June 30, 2009, after 33 years of service. He ... 2009, when he will focus on working,closely with his ...
Cached Medicine News:Health News:AMA Claims Victory With Record Breaking Settlement in Case Against Insurer 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 3Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 4Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 2Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 3Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 2Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 3Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 5Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 6Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 7Health News:Procter & Gamble Announces Organizational Changes 2